Clinical Trials
4 trialsNCT04529122 2026-05-27
A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing Test
Hoffmann-La Roche
Completed
NCT07446855 2026-05-26
PARTHENON
AstraZeneca
Phase 1/2 Recruiting
NCT07160725 2026-05-15
A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Phase 1/2 Recruiting
NCT06725758 2026-05-08
TEADES
Orion Corporation, Orion Pharma
Phase 1/2 Recruiting